Several landmark cardiovascular outcome trials have highlighted these benefits alongside meaningful reductions in microvascular complications, which are pivotal in the progression of diabetic complications
And in short that came out a few years after that STEP 1 trial what we did for the very first time is take individuals with obesity and pre-existing cardiovascular disease, like a prior stroke, prior heart attack, or peripheral arterial disease, called PAD, and they're on maximal therapy for their cardiovascular disease or stroke, and then randomized them on top of that to either semaglutide or placebo
Resources Metabolism
Permission helps take the power away from food so that, over time, food noise can lessen and you can feel more in control of your eating
Dual agonists produce more weight loss on average in clinical trials, making them objectively more effective for total weight loss
GLP-1 Starter Kit Starting a GLP-1 medication like semaglutide or tirzepatide can be exciting, but it also comes with a learning curve